ADVOCACY
-
Reimbursement of Altuviiio recommended, but…
MONTRÉAL, July 3, 2025 – In June, both Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) released...
-
Your FEEDBACK matters to us!
The CHS is currently developing the next CHS Strategic Plan. We would appreciate your insights into how we can further our mission and enhance our...
-
CHS survey of people with hemophilia A and their caregivers
In June and July 2024, the Canadian Hemophilia Society conducted an online survey regarding the lived experience of people with hemophilia A and their caregivers....
-
Novel treatments in bleeding disorders: The European Haemophilia Consortium Review
CLICK HERE to access the 2024 ISSUE TWO of the periodic review of novel treatments in hemophilia and other bleeding disorders by the European Haemophilia...
-
The value in sharing our strengths
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the International...